ELV

Elevance Health Inc
NYSEHEALTHCAREHEALTHCARE PLANS

Key Statistics

Market Cap
$91.81B
P/E Ratio
18.04
EPS
$23.55
Beta
0.63
52W High
$450.69
52W Low
$270.87
50-Day MA
$415.10
200-Day MA
$375.09
Dividend Yield
1.60%
Profit Margin
2.55%
Forward P/E
14.33
PEG Ratio
1.31

About Elevance Health Inc

Elevance Health Inc. is a health benefits company. The company is headquartered in Indianapolis, Indiana.

Official WebsiteUSAFY End: December

Fundamentals

Revenue (TTM)$201.83B
Gross Profit (TTM)$53.35B
EBITDA$8.71B
Operating Margin3.98%
Return on Equity11.50%
Return on Assets4.01%
Revenue/Share (TTM)$923.29
Book Value$206.75
Price-to-Book2.08
Price-to-Sales (TTM)0.46
EV/Revenue0.561
EV/EBITDA—
Quarterly Earnings Growth (YoY)17.90%
Quarterly Revenue Growth (YoY)1.40%
Shares Outstanding$216.06M
Float$215.57M
% Insiders0.18%
% Institutions95.24%

Historical Volatility

HV 10-Day
32.57%
HV 20-Day
30.31%
HV 30-Day
27.65%
HV 60-Day
26.12%
HV Rank
30.6%

Volatility is currently expanding

Analyst Ratings

Consensus ($482.38 target)
3
Strong Buy
12
Buy
7
Hold

Latest News

ELV or RVTY: Which Is the Better Value Stock Right Now?

Investors interested in Medical Services stocks are likely familiar with Elevance Health (ELV) and Revvity (RVTY). But which of these two companies is the best option for those looking for undervalued stocks?

Zacks Investment Research11/11/2026Positive
ELV vs. RVTY: Which Stock Is the Better Value Option?

Investors looking for stocks in the Medical Services sector might want to consider either Elevance Health (ELV) or Revvity (RVTY). But which of these two stocks offers value investors a better bang for their buck right now?

Zacks Investment Research10/23/2026Neutral
Elevance Health: Better Results, But Not Enough To Buy

Elevance Health raised its 2026 adjusted EPS guidance to at least $29, but the sustainability of its earnings recovery remains uncertain. Third-quarter adjusted EPS rose 15.9%, while nine-month operating gain declined 25.7%, highlighting the gap between improving earnings and underlying profitability. Health Benefits margins remain under pressure, particularly in Medicaid, despite improving medical cost trends and stronger quarterly results.

Seeking Alpha10/22/2026Neutral
What Elevance Health (ELV) Said on Its Q3 Earnings Call

Elevance Health NYSE: ELV raised its 2026 earnings outlook after reporting third-quarter adjusted diluted earnings per share of $6.99, exceeding the company's expectations as Medicaid, Medicare Advantage and Individual ACA businesses all performed better than anticipated.

MarketBeat10/21/2026Positive

Turn research into an automated options-selling system

Tiblio connects your broker and runs your put-and-call-writing strategy for you — on ELV and any ticker you trade — then tracks every position and per-strategy win rate.

See how it works

More HEALTHCARE Stocks

Data last updated: 11/14/2026